Apr 25, 2021
Mary Guillermin, Director of Communications and Senior Pellin Practicioner at the Pellin Institute International and author talks about her book John Guillermin: The Man, The Myth, The Movies a story about her husband the British writer and film director of such films as King Kong, The Towering Inferno, The Blue Max and...
Apr 25, 2021
Mary Guillermin, Director of Communications and Senior Pellin Practicioner at the Pellin Institute International and author talks about her book John Guillermin: The Man, The Myth, The Movies a story about her husband the British writer and film director of such films as King Kong, The Towering Inferno, The Blue Max and...
Mar 17, 2021
Dr. Steve Kanes, Chief Medical Officer, Sage Therapeutics takes the view that mental disorders and brain health disorders need to be treated like any other medicine. Driving this paradigm shift is the development of breakthrough zuranalone, an oral limited-time treatment to replace taking medicine chronically for those...
Mar 17, 2021
Dr. Steve Kanes, Chief Medical Officer, Sage Therapeutics takes the view that mental disorders and brain health disorders need to be treated like any other medicine. Driving this paradigm shift is the development of breakthrough zuranalone, an oral limited-time treatment to replace taking medicine chronically for those...
Nov 12, 2017
Transcranial magnetic stimulation (TMS) is a method of noninvasive neuromodulation being used to treat depression. Joe Perekupka, VP of Sales Operations at Brainsway discusses their proprietary deep TMS (dTMS) technology which is able to affect areas of the brain previously unreachable by standard TMS. The Brainsway...